New epilepsy drug shows promise for kids in long-term safety trial

NCT ID NCT01364597

First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 25 times

Summary

This study tested the safety of brivaracetam, a seizure medicine, in 257 children with epilepsy when added to their current treatment. The goal was to see how many children had side effects over time. Results help doctors understand if this drug is safe for long-term use in kids.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • N01266 101

    Saint Paul, Minnesota, 55102, United States

  • N01266 103

    Wellington, Florida, 33470, United States

  • N01266 104

    Rochester, New York, 14642, United States

  • N01266 105

    Buffalo, New York, 14222, United States

  • N01266 106

    Boston, Massachusetts, 02111, United States

  • N01266 107

    Cincinnati, Ohio, 45229, United States

  • N01266 108

    Gulf Breeze, Florida, 32561, United States

  • N01266 111

    Columbus, Ohio, 43205, United States

  • N01266 113

    Chesterfield, Missouri, 63017, United States

  • N01266 114

    Pittsburgh, Pennsylvania, 15201, United States

  • N01266 117

    Houston, Texas, 77030, United States

  • N01266 118

    Chicago, Illinois, 60611, United States

  • N01266 201

    Leuven, Belgium

  • N01266 202

    Brussels, Belgium

  • N01266 203

    Brussels, Belgium

  • N01266 204

    Leuven, Belgium

  • N01266 206

    Paris, France

  • N01266 207

    Lille, France

  • N01266 209

    Freiburg im Breisgau, Germany

  • N01266 210

    Budapest, Hungary

  • N01266 211

    Cork, Ireland

  • N01266 212

    Messina, Italy

  • N01266 213

    Parma, Italy

  • N01266 215

    London, United Kingdom

  • N01266 218

    Bayern, Germany

  • N01266 222

    Debrecen, Hungary

  • N01266 223

    Aguascalientes, Mexico

  • N01266 224

    Budapest, Hungary

  • N01266 230

    Roma, Italy

  • N01266 232

    Miskolc, Hungary

  • N01266 237

    Durham, North Carolina, 27710, United States

  • N01266 238

    Pavia, Italy

  • N01266 239

    Pavia, Italy

  • N01266 240

    Prague, Czechia

  • N01266 243

    Los Angeles, California, 90027, United States

  • N01266 247

    Budapest, Hungary

  • N01266 248

    Seville, Spain

  • N01266 252

    New York, New York, 10029, United States

  • N01266 256

    Roma, Italy

  • N01266 301

    Palma de Mallorca, Spain

  • N01266 306

    Madrid, Spain

  • N01266 308

    Valencia, Spain

  • N01266 309

    Barcelona, Spain

  • N01266 401

    Poznan, Poland

  • N01266 402

    Krakow, Poland

  • N01266 403

    Gdansk, Poland

  • N01266 404

    Bialystok, Poland

  • N01266 405

    Wroclaw, Poland

  • N01266 406

    Kielce, Poland

  • N01266 407

    Szczecin, Poland

  • N01266 502

    Hradec Králové, Czechia

  • N01266 504

    Ostrava Prouba, Czechia

  • N01266 603

    Guadalajara, Mexico

  • N01266 609

    Culiacán, Mexico

  • N01266 610

    Monterrey, Mexico

  • N01266 611

    Chihuahua City, Mexico

Conditions

Explore the condition pages connected to this study.